Accelerating patient access to oncology medicines with multiple indications in Europe

Background: In recent years, innovation in oncology has created new challenges for pricing and reimbursement systems. Oncology medicines with multiple indications face a number of access challenges: (1) the number of assessments and administrative burden; (2) aligning price to different values of th...

Full description

Bibliographic Details
Main Authors: R. Lawlor, T. Wilsdon, E. Darquennes, D. Hemelsoet, J. Huismans, R. Normand, A. Roediger
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Journal of Market Access & Health Policy
Subjects:
Online Access:http://dx.doi.org/10.1080/20016689.2021.1964791